(1,3)-Beta-D-Glucan (Aspergillus) Test in UAE

(1,3)-Beta-D-Glucan test in Dubai and across the UAE to detect early signs of fungal infections like Aspergillus. This sensitive blood test helps identify invasive fungal infections in high-risk patients — including those with weakened immunity, post-transplant, or on chemotherapy. Results available within 15 days.

Overview

The (1,3)-Beta-D-Glucan test is a serum-based biomarker assay that detects a key component of fungal cell walls. It is highly useful in the early identification of invasive fungal infections, including Aspergillus, Candida, and Pneumocystis jirovecii. This test does not identify the specific fungus but signals the presence of a fungal infection, enabling earlier treatment. Results are typically available within 15 days.

Why You Need This Test

• Early detection of invasive fungal infections in immunocompromised individuals (e.g., cancer, transplant, or ICU patients).
• Monitor patients on long-term steroids or immunosuppressive therapy.
• Support diagnosis when symptoms include fever, cough, chest pain, or shortness of breath unresponsive to antibiotics.
• Complement imaging (e.g., CT scan) and other tests like galactomannan or fungal culture.
• Reduce delays in starting antifungal therapy — critical for survival in high-risk groups.
• Non-invasive alternative to lung biopsy for suspected Aspergillus.
• Available with home sample collection across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms

• Persistent fever not responding to antibiotics.
• Dry cough or chest pain — may mimic pneumonia.
• Shortness of breath or hypoxia.
• Fatigue and night sweats.
• Hemoptysis (coughing up blood) in advanced cases.

Risk Factors

• Weakened immune system: HIV/AIDS, chemotherapy, organ/bone marrow transplant.
• Long-term corticosteroid use or immunosuppressants.
• Lung diseases: COPD, cystic fibrosis, prior TB.
• ICU admission with mechanical ventilation.
• Neutropenia (low white blood cells).
• Exposure to construction/dust (source of Aspergillus spores).

How the Test Works

The test detects (1,3)-beta-D-glucan, a polysaccharide found in the cell walls of many pathogenic fungi (except Cryptococcus and mucormycetes). A positive result suggests fungal invasion, even before cultures turn positive.

• Step 1 — Appointment: visit a certified lab or book home blood collection (available in Dubai, Abu Dhabi, Sharjah, and other Emirates).
• Step 2 — Blood draw: a trained technician collects a serum sample (plain tube) via venipuncture (takes under 5 minutes).
• Step 3 — Lab analysis: performed using sensitive immunoassay to detect glucan levels.
• Step 4 — Results: delivered securely within 15 business days.

This test supports early clinical decisions — especially when imaging or cultures are inconclusive.

Specimen (Sample Type)

• Required sample: Serum, Plain tube
• Volume: 1 mL
• Collection method: standard venipuncture
• Transport: 2–8°C (refrigerated), protect from light
• Avoid: IV immunoglobulins, albumin, or hemodialysis within 24 hours (can cause false positives)

Risks & Safety

• Mild pain or bruising at the needle site (temporary).
• Dizziness (rare, especially in frail patients).
• Very low infection risk with sterile technique.
• No special risks from the test itself — it’s a standard blood draw.

Result Interpretation

Normal Range

• < 60 pg/mL: Negative — no significant fungal antigen detected.

Positive Result (> 60 pg/mL)

• Suggests invasive fungal infection (e.g., Aspergillus, Candida, Pneumocystis).
• Does not identify the specific fungus — clinical correlation needed.
• May require follow-up with galactomannan test, CT scan, or bronchoalveolar lavage.

Indeterminate (40–60 pg/mL)

• Borderline result — repeat testing or clinical monitoring advised.

Consequences if Untreated

• Progression to severe infection: invasive aspergillosis can spread to brain, kidneys, or heart.
• Lung damage: cavities, hemorrhage, or respiratory failure.
• High mortality: up to 50–90% in immunocompromised patients if diagnosis is delayed.
• Increased ICU stay and treatment complexity.

Factors Affecting Test Results

• False positives: due to IV immunoglobulins, albumin, dialysis filters, gauze, or bacteremia (Streptococcus pneumoniae).
• False negatives: early infection, localized disease, or use of antifungal medications.
• Recent surgery or IV fluids containing glucan contaminants.
• Type of fungus: Cryptococcus and mucormycetes do not produce beta-D-glucan.

FAQs

Limitations

• Not specific to Aspergillus — detects multiple fungi.
• Cannot replace culture or imaging — must be interpreted with clinical findings.
• May yield false positives due to certain IV products or bacterial infections.
• Not useful for Mucor, Rhizopus, or Cryptococcus.

Book Your (1,3)-Beta-D-Glucan (Aspergillus) Test Today

Don’t wait — early detection saves lives in fungal infections.

• Home Sample Collection Available (Across Abu Dhabi, Dubai, Sharjah, Ajman, RAK, Umm Al Quwain, Fujairah)
• Fast, Accurate, Confidential Results in 15 Days
• Price: AED 250
• ✅ Certified Labs
• 👩‍⚕️ Licensed Technicians
• 🔒 Secure Reporting